Give Kids a Chance Act of 2024
Latest action · Sep 24, 2024 Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedMay 17, 2023
- Passed HouseSep 23, 2024
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Give Kids a Chance Act of 2023
This bill authorizes certain targeted clinical trials involving combinations of drugs to treat pediatric cancer.
Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations so as to authorize investigations of new drugs that are used in combination with active ingredients that have already been approved and that (1) have been determined to be the standard of care for treating a pediatric cancer, or (2) have been approved to treat an adult cancer and are directed at molecular targets for pediatric cancer.
The Food and Drug Administration must issue guidance and report on the bill's implementation. The Government Accountability Office must report on the effectiveness of the bill's changes with respect to the development of pediatric cancer drugs.
Cosponsors 235
Members who signed on, in the order they did. Signatures ran from May 17, 2023 to Jul 10, 2024; 13 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-CA | Anna G. Eshoo | Original | May 17, 2023 |
| R-MI | Bill Huizenga | Original | May 17, 2023 |
| R-OH | Bill Johnson | Original | May 17, 2023 |
| R-PA | Brian K. Fitzpatrick | Original | May 17, 2023 |
| R-NJ | Christopher H. Smith | Original | May 17, 2023 |
| D-MN | Dean Phillips | Original | May 17, 2023 |
| R-NE | Don Bacon | Original | May 17, 2023 |
| R-WI | Glenn Grothman | Original | May 17, 2023 |
| R-GU | James C. Moylan | Original | May 17, 2023 |
| D-WA | Kim Schrier | Original | May 17, 2023 |
| R-PA | Mike Kelly | Original | May 17, 2023 |
| R-FL | Vern Buchanan | Original | May 17, 2023 |
| R-CA | Young Kim | Original | May 17, 2023 |
| D-NH | Ann M. Kuster | May 22, 2023 | |
| R-SC | Joe Wilson | May 22, 2023 |
Committees 2
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred May 17, 2023Markup Sep 18, 2024Reported Sep 20, 2024 |
| Health Subcommittee | Referred May 19, 2023Markup May 16, 2024Reported May 16, 2024 | |
| Senate | Health, Education, Labor, and Pensions Committee | Referred Sep 24, 2024 |
Actions 15
Everything that happened, newest first.
- Sep 24, 2024Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Sep 23, 2024Mr. Bucshon moved to suspend the rules and pass the bill, as amended.
- Sep 23, 2024Considered under suspension of the rules. (consideration: CR H5582-5587)
- Sep 23, 2024DEBATE - The House proceeded with forty minutes of debate on H.R. 3433.
- Sep 23, 2024Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5582-5585)
In the Congressional Record 2
Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.
| Where | In the Record | Members | Date |
|---|---|---|---|
| Senate | Debate and remarks S7307 | Michael F. Bennet D-CO, Rand Paul R-KY | Dec 20, 2024 |
| House | Debate and remarks H5582–H5587Text printed H5582–H5585 | Anna G. Eshoo D-CA, Diana Harshbarger R-TN, Frank Pallone, Jr. D-NJ, Gus M. Bilirakis R-FL, Larry Bucshon R-IN, Michael T. McCaul R-TX | Sep 23, 2024 |
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Committee report
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 169, no. 83, May 17, 2023, page H2428.
Related bills 3
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| S 1214 | RARE Act | Related bill | Jun 22, 2023 |
| S 2897 | Give Kids a Chance Act of 2023 | Identical bill | Sep 21, 2023 |
| HR 7383 | RARE Act | Related bill | Feb 16, 2024 |
Titles 5
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes.
- Short Title(s) as Introduced
- Give Kids a Chance Act of 2023
- Short Title(s) as Reported to House
- Give Kids a Chance Act of 2024
- Short Title(s) as Passed House
- Give Kids a Chance Act of 2024
- Short Titles from RFS (Referred to Senate) bill text
- Give Kids a Chance Act of 2024
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 4
Each version as it was printed, newest first.
- Sep 24, 2024Referred in Senate
- Sep 23, 2024Engrossed in House
- Sep 20, 2024Reported in House
- May 17, 2023Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.